|
Treatment
|
Overall survival
|
Relapse
|
|---|
|
Trials
|
aEvents/Patients
|
%
|
Trials
|
bEvents/Patients
|
%
|
|---|
|
CCRT
|
1
|
237/317
|
74.8
|
1
|
43/317
|
13.6
|
|
RS
|
7
|
338/468
|
72.2
|
6
|
175/493
|
35.5
|
|
CCRT+RS
|
3
|
156/191
|
81.7
|
2
|
37/108
|
34.3
|
|
NACT+RS
|
8
|
512/730
|
70.1
|
6
|
106/593
|
17.9
|
|
RT + RS
|
4
|
173/227
|
76.2
|
3
|
41/173
|
23.7
|
|
RT
|
4
|
276/409
|
67.5
|
3
|
68/266
|
25.6
|
|
Total
| |
1692/2342
|
72.2
| |
470/1950
|
24.1
|
- Abbreviations: CCRT concomitant chemotherapy and radiotherapy, RS Radical Surgery, NACT neoadjuvant chemotherapy, RT radiotherapy. aPeople who were alive during follow-up. bPatients with local or distant metastasis
